korumedical.com (KRMD) - התחייבויות לטווח ארוך להון

KORU Medical Systems (KRMD) aims to transition the therapy of rare pathologies to a home-based format by creating advanced portable injection devices. The business model relies on the high scalability of consumables production, which optimizes costs as volumes grow. This chart on GURU.Markets, where the indicator equals 0.14, complements data on drug delivery automation that minimizes the involvement of medical personnel in patient care.

For a conservative investor, this ratio of long-term debt to equity serves as a measure of long-term solvency, determining the proportion of borrowed funds with a maturity of over one year within the equity structure. Low leverage, combined with the scalable sales model for infusion therapy consumables at KORU Medical Systems (KRMD), minimizes bankruptcy risk and confirms the stability of the financial foundation during business expansion.